Dr. Amy Goldstein, a past member of the Board of Trustees of UMDF, current member of the Scientific and Medical Advisory Board of the UMDF, is an attending physician with the Division of Human Genetics at Children’s Hospital of Philadelphia. She was on faculty at Children’s Hospital of Pittsburgh of UPMC in the Division of Pediatric Neurology. She is board certified in Neurology and Psychiatry with Special Qualifications in Child Neurology. She is currently an Associate Professor at the University of Pennsylvania School of Medicine.
She began a multidisciplinary mitochondrial disease clinic in 2007 and became the Director of Neurogenetics & Metabolism and the site Principle Investigator for NAMDC (the North American Mitochondrial Disease Consortium) while in Pittsburgh. She is currently the Clinical Director of the Mitochondrial Medicine Frontier Program at CHOP, since July 2017. She is also immediate past-president of the Mitochondrial Medicine Society. Her clinical research interests include improving neuroprotection, fatigue and exercise intolerance, and developing common patient-centered outcome measures for clinical trials.